GENERAL CONSIDERATIONS {#cesec1}
======================

Leukogram Evaluation {#cesec2}
--------------------

I.The complete blood count (CBC) evaluates white blood cells (WBCs \[leukocytes\]), red blood cells (RBCs \[erythrocytes\]), and platelets.II.The leukogram is composed of total, relative, and absolute differential leukocyte counts and morphology evaluation.A.Absolute differential leukocyte counts (total WBC × WBC type relative percent) are the preferred evaluation method and result in fewer interpretation errors.B.Canine and feline leukocytes are present in the following numeric order of prevalence in healthy animals: neutrophils, lymphocytes, monocytes, eosinophils, and basophils.III.Published total leukocyte counts in health are 6000 to 17,000/μL in dogs and 5500 to 19,500/μL in cats ([@bib41]).A.These numbers are provided as guidelines; use the reference ranges provided by each laboratory to interpret the leukogram.B.Interpretation of the leukogram is based on the absolute leukocyte count (reported as numbers/μL) rather than the relative percentages.C.The absolute numbers of the various WBCs are altered by physiological, pathologic, or pharmacological processes.D.Increased numbers of leukocytes are denoted by the addition of the suffix "ilia" or "osis."1.*Neutrophilia* is defined as absolute neutrophil counts \>12,000/μL in dogs and \>12,500/μL in cats; it is the most common contributor to leukocytosis.2.*Monocytosis* is defined as absolute monocyte counts \>1400/μL in dogs and \>850/μL in cats.3.*Lymphocytosis* is defined as absolute lymphocyte counts \>2900/μL in dogs and \>7000/μL in cats.4.*Eosinophilia* is defined as absolute eosinophil counts \>1300/μL in dogs and \>750/μL in cats; it generally occurs with hypersensitivity reactions or parasitic infections.5.*Basophilia* is defined as absolute basophil counts \>140/μL in dogs and \>200/μL in cats.6.Basophilia is rare, is often accompanied by eosinophilia, and is associated with parasitic diseases (particularly dirofilariasis); hypersensitivity reactions; inflammation; neoplasia (basophilic leukemia, mast cell tumor/mastocytosis, lymphomatoid granulomatosis, essential thrombocythemia); and drug reactions (heparin, penicillin).E.Decreased numbers of leukocytes are denoted by the addition of the suffix "penia" or "cytopenia."1.*Neutropenia* is defined as absolute neutrophil counts of \<2900/μL in dogs and \<2500/μL in cats.2.*Lymphopenia* is defined as absolute lymphocyte counts \<400/μL in dogs and \<1500/μL in cats.3.Monocytopenia and basopenia occur infrequently and are of no clinical importance.4.Eosinopenia and basopenia are difficult to define, because the lower limit of normal in dogs and cats typically extend to 0/μL.a.Eosinopenia may occur with acute inflammation or infection.b.Eosinopenia also may follow endogenous corti-costeroid release secondary to stress, trauma, or hyperadrenocorticism, and may be associated with exogenous corticosteroid or adrenocorticotropic hormone (ACTH) administration.IV.Assessment of WBC morphology is extremely important.A.Altered WBC morphology and the presence of cytoplasmic inclusions are important indicators of physiological abnormalities or disease ([Tables 65-1](#cetable1){ref-type="table"} and [65-2](#cetable2){ref-type="table"} ).TABLE 65-1Morphological Alterations in LeukocytesALTERATIONCELL TYPE AFFECTEDKEY MORPHOLOGICAL FEATURE(S)INTERPRETATIONCAUSESREFERENCESHypersegmentationNeutrophils≥ 5 nuclear lobesIncreased vascular transit timeIncreased endogenous (protracted stress, hyperadrenocorticism) or exogenous corticosteroid administration[@bib58]HyposegmentationNeutrophilsRound, bean- or horseshoe-shaped nucleiCellular immaturity or failure of the nucleus to segment (congenital or acquired)Left shift: release of immature neutrophils or Pelger-Huët anomaly[@bib37], [@bib58]Toxic changeNeutrophilsCytoplasmic abnormalities:Döhle bodies (basophilic, pale, angular, peripherally located inclusions), vacuolation, basophilia, toxic granulation, and/or giant neutrophilsAccelerated production of neutrophils and decreased neutrophil maturation time in the marrowAffected cells lack some functions (guarded prognosis)Can be a sensitive diagnostic aid for inflammation, systemic disease, or drug toxicity, as they may precede changes in neutrophil number and appearance of immature formsSevere inflammation from localized or systemic infection, endotoxemia, sterile inflammation, or drug toxicity[@bib3]EDTA artifactNeutrophilsCytoplasmic vacuolization, membrane irregularity, and pyknosisArtifact (must be differentiated from toxic change)Prolonged exposure to EDTA (delayed blood smear preparation)[@bib23]Reactive lymphocytesLymphocytesIncreased cell size, deeply basophilic cytoplasm, perinuclear clear zone, aggregated chromatin, and indistinct nucleoliAntigenic stimulationMany causes; occurs secondary to inflammation, infection, or recent immunization[@bib37]Large granular lymphocytesLymphocytesVariable numbers of azurophilic to eosinophilic cytoplasmic granulesDogs: small granules clustered near the nucleusCats: larger, evenly dispersed granulesNeoplasia or inflammationNeoplasia or inflammation[@bib70]Lymphocytes in Sézary syndromeLymphocytesLarge circulating neoplastic lymphocytes with intensely cleaved nuclei with prominent nucleoliNeoplasiaNeoplasia[@bib18]Plasma cellsLymphocytesCharacterized by basophilic cytoplasm, eccentrically placed nucleus with condensed chromatin, and prominent perinuclear Golgi zoneRarely found in circulationAntigenic stimulation from infection, inflammation, hypersensitivity reactions, systemic disease[@bib58]Degranulation or vacuolation of eosinophils (dogs)EosinophilsComplete or partial clearing of eosinophilic staining of granulesArtifactUnknown, but not indicative of injury or abnormal function[@bib58][^1]TABLE 65-2Leukocyte Cytoplasmic InclusionsINCLUSIONCELL(S) AFFECTEDKEY MORPHOLOGIC FEATURESREFERENCESBacteriaNeutrophils, monocytes, eosinophils (rarely)Dogs, cats: positively or negatively staining rods or cocci[@bib66]*Hepatozoon* spp. gametocytesNeutrophils or monocytesDogs: oval, unstained to pale blue basophilic inclusions (5-10 μm)[@bib4], [@bib52]Canine distemper virusLeukocytes (particularly lymphocytes), red blood cellsDogs: round to irregularly shaped, homogeneous, blue-gray to magenta, intracytoplasmic inclusions[@bib42]*Histoplasma capsulatum*Neutrophils, monocytes, eosinophils (rarely)Dogs, cats: round to oval, uniform, basophilic yeast (2-4 μm) with dark central area and clear halo[@bib9], [@bib10])*Ehrlichia* spp. morulae*E. ewingii, E. equi,* or human granulocytotropic *Ehrlichia* spp.: neutrophils and eosinophils*E. canis:* monocytes, lymphocytesDogs: magenta to basophilic inclusion (2-6 μm) resembling a mulberry[@bib14], [@bib57]*Leishmania* spp. amastigotesNeutrophilsDogs: 1-2 small, round to oval organisms with oval nucleus, basophilic ventral kinetoplast, and light blue cytoplasm[@bib58]HemosiderinNeutrophils and monocytesDogs: brown crystals (1-4 μm) that stain positively with Prussian blue stain; reported with immune-mediated hemolytic anemia[@bib21]B.Abnormal morphology does not always indicate abnormal or compromised cell function; normal morphology does not guarantee normal cell function.C.Characteristic and cyclical patterns of changes in WBC numbers over time are unique to certain disorders (e.g., canine cyclic hematopoiesis).

Peripheral Blood Neutrophil Pools {#cesec3}
---------------------------------

I.Neutrophils in peripheral blood randomly disperse into two interchangeable populations---the circulating and the marginated pools.II.The circulating pool includes neutrophils located within the vasculature that are sampled with routine blood collection and quantified in the CBC.III.The marginated pool is composed of neutrophils that are loosely attached to capillary and venule endothelial surfaces and, therefore, are not sampled during blood collection procedures.

Bone Marrow Neutrophil Production and Kinetics {#cesec4}
----------------------------------------------

I.Neutrophil production and maturation occurs in the bone marrow, with precursors progressing through stages, such as myeloblast, progranulocyte, myelocyte, metamyelocyte, band neutrophil, and mature segmented neutrophil.II.Neutrophil precursors are divided into two pools based on their mitotic capabilities.A.The proliferation-mitotic pool is composed of myeloblasts, progranulocytes, and myelocytes.B.The storage-maturation pool (no cell division) is composed of metamyelocytes, band, and segmented neutrophils.III.The marrow transit time (myeloblast to released segmented neutrophils) is 3.5 to 6 days.

ALTERATIONS IN WHITE BLOOD CELL NUMBERS AND MORPHOLOGY {#cesec5}
======================================================

Neutrophilia {#cesec6}
------------

See [Box 65-1](#cetextbox1){ref-type="boxed-text"} .Box 65-1Causes of Neutrophilia\*\*Absolute neutrophil counts \>12,000/μL in dogs and \>12,500/μL in cats.CausesSpecies AffectedInflammation Infectious agents  Bacteria: numerous speciesDog, cat  Fungi: numerous speciesDog, cat  Rickettsia: Rocky Mountain spotted feverDog  Viruses: canine distemper, feline rhinotracheitis, feline calicivirusDog, cat  Parasites: numerous speciesDog, cat  Protozoa: *Hepatozoon americanum*Dog Tissue necrosis  Thrombosis/infarctionDog, cat  Metabolic injury: uremiaDog, cat  Physical injury: surgery, trauma, burns, frostbiteDog, cat  NeoplasiaDog, cat Immune-mediated diseases  Immune-mediated hemolytic anemiaDog, cat  PolyserositisDog, cat  PolymyositisDog, cat  Rheumatoid arthritisDog, cat  Systemic necrotizing vasculitisDog (beagle)  Lupus erythematosusDog, catPhysiologic leukocytosis: epinephrine release resulting from excitement, fear, exerciseDog, catCorticosteroid-induced leukocytosis: increased endogenous or exogenous steroids, ACTH administrationDog, catNeoplasia Leukemia: several typesDog, cat Paraneoplastic syndrome: benign and malignant tumorsDog, catGenetic disorders: CD11b/CD18 leukocyte adhesion deficiencyDog (Irish setter)Drug administration: recombinant human or canine colony-stimulating factorDog, catDrug toxicity: early estrogen toxicosisDogMiscellaneous HemolysisDog, cat HemorrhageDog, catToxemia/toxicity Blue-green algae toxicityDog BotulismDog, cat EndotoxemiaDog, cat UremiaDog, cat[^2]*ACTH,* Adrenocorticotropic hormone.© 2008 Iowa State University Press2008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.(Mahaffey EA: Quality control, test validity, and reference values. p. 331. In Latimer KS, Mahaffey, Prasse KW (eds): Duncan and Prasse\'s Veterinary Laboratory Medicine: Clinical Pathology. 4th Ed. Iowa State University Press, Ames, 2003)

Neutropenia {#cesec7}
-----------

###  {#cesec8}

#### Definition {#cesec9}

I.Neutropenia is characterized by a neutrophil count below the lower limit of the reference range (\<2900/μL in dogs and \<2500/μL in cats) ([@bib41]).II.It is common in dogs and cats and is often accompanied by leukopenia.III.Neutropenia accompanied by anemia and thrombocytopenia indicates pancytopenia and is suggestive of bone marrow injury or effacement.

#### Causes and Pathophysiology {#cesec10}

I.General mechanisms of neutropenia consist of decreased bone marrow production and tissue utilization exceeding marrow production and release ([Box 65-2](#cetextbox2){ref-type="boxed-text"} ).Box 65-2Causes of Neutropenia\*\*Absolute neutrophil counts \<2900/μL in dogs and \<2500/μL in catsCausesSpecies AffectedTissue utilization in excess of bone marrow release Infectious agents  Acute endotoxemia, septicemiaDog, cat  Bacteria: numerous speciesDog, cat  Rickettsia: *Ehrlichia canis*Dog  Viruses: canine parvovirus, canine distemper virus, infectious canine hepatitis, FeLV, FIVDog, catParasites: *Babesia canis*DogDecreased bone marrow production Drug toxicity  Estrogen toxicosis: iatrogenic, prolonged estrus, or Sertoli cell tumor--induced hyperestrogenismDog  GriseofulvinCat  ChloramphenicolCatIdiosyncratic drug reactions  CephalosporinsDog, cat  Noxzema skin cremeDog, cat  PhenylbutazoneDog  Trimethoprim-sulfadiazineDog  PhenobarbitalDog  ThiacetarsamideDog  MethimazoleCatMyelodysplasia and myeloproliferative diseasesDog, cat Lymphoproliferative diseaseDog, cat Myelophthisis  Neoplasia: metastatic carcinomaDog  Granulomatous inflammation: disseminated *Histoplasma capsulatum*Dog, cat Myelofibrosis and osteopetrosisDog Bone marrow necrosisDog, cat RadiationDog, catShifts from the circulating to marginated neutrophil pool EndotoxemiaDog, cat AnaphylaxisDog, catCongenital disorders Cyclic hematopoiesisDog (gray-coated collie) Inherited vitamin B~12~ malabsorptionDog (giant schnauzer)Destruction/sequestration of neutrophils Immune-mediated neutropeniaDog Hemophagocytic syndromeDog[^3]© 2008 Iowa State University Press2008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.(Mahaffey EA: Quality control, test validity, and reference values. p. 331. In Latimer KS, Mahaffey, Prasse KW (eds): Duncan and Prasse\'s Veterinary Laboratory Medicine: Clinical Pathology. 4th Ed. Iowa State University Press, Ames, 2003)II.Neutropenia can be secondary to increased margination, sequestration, hemophagocytic syndrome, and immune-mediated damage to circulating neutrophils or granulo-cytic precursors in the bone marrow.III.Neutropenia can be a negative prognostic indicator associated with increased mortality; the more severe the neutropenia, the greater the risk of infection ([@bib3]).IV.Neutropenia resulting from tissue utilization in excess of marrow production can occur with severe, localized bacterial infections involving body cavities, the uterus, the respiratory or gastrointestinal (GI) tracts, or during generalized septicemia.V.Neutropenia can be associated with neutrophil toxicity.VI.Marrow suppression resulting in decreased leukocyte production may arise with the following:A.Total body ionizing radiationB.Myelosuppression with chemotherapeutic agents (see Chapter 72)1.Examples include cyclophosphamide, daunomycin, dimethyl myleran, doxorubicin, 6-thioguanine, azathioprine, cisplatin, carboplatin, chlorambucil, melphalan, methotrexate, mitoxantrone, and combination therapy with vincristine and L-asparaginase.2.The marrow neutrophil proliferation-mitotic pool is most sensitive to chemotherapeutics.a.Differentiated cells in the maturation-storage pool are unaffected, so release of mature neutrophils continues for 5 to 10 days.b.A neutropenic nadir often occurs during these 5 to 10 days as a result of decreased marrow production and the short (6-hour) lifespan of the circulating neutrophil.3.Chemotherapy-induced thrombocytopenia occurs in 1 to 2 weeks (circulating lifespan of platelets is 10 days).4.Anemia is uncommon.C.Estrogen toxicosis in dogs1.Sources of estrogen exposure include the following:a.Diethylstilbestrol or estradiol cyclopentylpropionate therapy used for mismating, urinary incontinence, or infertility in females may be a cause.b.With exogenous estrogen therapy for perianal gland tumors in males, pancytopenia can occur with the neutropenia.c.Excessive endogenous estrogen with interstitial and Sertoli cell tumors (males) and granulosa cell tumors (females) can also be associated with pancytopenia.2.Sequential hematological abnormalities in canine estrogen toxicosis consist of the following:a.Immediate leukocytosis followed by rapid leu-kopeniab.Thrombocytosis followed by rapid thrombocytopeniac.Slow development of anemia and pancytopenia within 1 monthD.Prolonged (14 to 21 days) chloramphenicol therapy in cats: leukopenia and neutrophils with Döhle bodiesE.Idiosyncratic drug reactions with either neutropenia or pancytopenia1.Antibiotics: cephalosporins, trimethoprim-sulfadiazine2.Thiacetarsamide3.Griseofulvin4.Phenobarbital5.Phenylbutazone6.Albendazole7.Captopril8.Medicated skin cream *(Noxzema)*9.Methimazole10.Trimeprazine tartrateF.Infectious causes of neutropenia or pancytopenia (see Chapters 112 and 115)1.Parvovirus infection of dogs and cats (feline panleukopenia)2.Feline leukemia virus (FeLV)3.Feline immunodeficiency virus (FIV)4.Canine ehrlichiosisVII.Neutropenia or pancytopenia from significantly decreased hematopoiesis can result from the following:A.Reduction or complete effacement of the marrow space with bone marrow necrosis (rare) or myelophthisic diseaseB.Causes of myelophthisic disease in dogs and cats1.Myelofibrosis (see Chapter 66)2.Osteopetrosis: rare3.Myeloproliferative diseases or myelodysplasia (see Chapter 66)4.Multicentric lymphoma (lymphosarcoma \[LSA\]) (see Chapter 69)5.Disseminated granulomatous disease (e.g., systemic mycoses)6.Metastatic neoplasiaVIII.Neutrophils shift rapidly from the circulating to marginated pool, especially during episodes of anaphylaxis or endotoxemia in dogs (pseudoneutropenia).IX.Hemophagocytic syndrome is a rare event.A.Hematology findings consist of cytopenias involving two or more of the hematologic cell lines and circulating fragments of erythrocytes.B.Bone marrow aspirate reveals increased numbers of macrophages containing phagocytized hematopoietic precursors, and predominantly erythroid precursors, with fewer neutrophils and platelets.X.Uncommon causes of neutropenia include the following:A.Immune-mediated neutropenia can be idiopathic, drug-related, or associated with other immune-mediated diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus).1.Presumptive diagnosis can be made with clinical response to immunosuppressive doses of corticosteroids and with termination of therapy in cases of drug-related neutropenia.2.Definitive diagnosis requires demonstration of antineutrophil antibodies, which is difficult owing to fragility of the neutrophils and potential release of intracellular enzymes.B.Canine cyclic hematopoiesis, a genetic disorder specific for gray-coated collies, is characterized by continuous, abnormal 2- to 4-day cycles of neutropenia.1.Affected dogs exhibit recurrent infections by 8 weeks of age.2.Death usually occurs by approximately 3 years of age from septicemia or systemic amyloidosis.C.Inherited vitamin B~12~ (cobalamin) malabsorption in giant schnauzers results in failure to express the necessary receptor for normal intestinal cobalamin absorption.1.Cobalamin deficiency induces maturation abnormalities in hematopoietic precursors.2.Characteristic findings consist of neutropenia, neutrophil hypersegmentation, nonregenerative anemia, nucleated red blood cells (nRBCs) with nuclear:cystoplasmic asynchrony, thrombocytosis, and rare giant platelets.

#### Diagnosis {#cesec11}

I.Perform routine CBCs to identify and monitor neutro-penia and concurrent hematological abnormalities.II.Question clients regarding the administration of chemotherapeutics, estrogen, or other hematotoxic compounds.III.Serological and other tests are used for diagnosis of canine and feline viral and ehrlichial diseases (see Chapters 112 and 115).IV.Bone marrow evaluation is a useful procedure in cases of neutropenia when the aforementioned causes of neutropenia or pancytopenia have been eliminated, and may reveal the following:A.Myeloproliferative disease: blast cells in circulation and in bone marrow samples; cytochemical stains required for definitive diagnosis (see Chapter 66).B.Myelofibrosis: obliteration of marrow spaces by increased fibrous connective tissueC.Myelodysplasia: peripheral cytopenias to pancyto-penia, abnormal cellular morphology and/or maturation, and hypercellular bone marrow with or without blast cellsD.Identification of bone marrow abnormalities in inherited vitamin B~12~ deficiency: decreased cellularity, hypersegmented neutrophils, giant neutrophil precursors, and erythroid dysplasiaV.Measure serum cobalamin concentrations in giant schnauzers with suspected inherited cobalamin malabsorption.

#### Treatment {#cesec12}

I.Consider discontinuing or delaying chemotherapy in animals with neutrophil counts of \<1000/μL, and starting prophylactic broad-spectrum antibiotics, because they are predisposed to sepsis ([@bib37]).II.Lithium carbonate (11 mg/kg PO BID for 6 weeks) may reverse marrow hypoplasia and pancytopenia secondary to estrogen toxicosis in dogs ([@bib25]).III.Lithium carbonate at 21 to 26 mg/kg/day PO may partially alleviate neutropenia of canine cyclic hematopoiesis, but can have toxic effects at this latter dose ([@bib8]).IV.Recombinant human granulocyte colony-stimulating factor (G-CSF, 2.5 to 10 μg/kg/day SC for 3 to 5 days) can be used for short-term management of neutropenia in dogs and cats, but neutralizing antibodies develop in cats and dogs within 14 and 21 days, respectively; therefore, long-term use is not recommended ([@bib51]; [@bib54]).V.Parenteral administration of 1 mg cobalamin once monthly has resulted in temporary remission; no improvement occurs with oral therapy ([@bib19]).VI.Bone marrow transplantation and lentivirus-mediated G-CSF therapy have been used experimentally to treat or lessen the severity of canine cyclic hematopoiesis ([@bib40]; [@bib75]).

#### Monitoring of Animal {#cesec13}

I.Prognosis for recovery from neutropenia is dependent on the cause and reversibility of bone marrow damage.II.Neutrophil counts usually rebound when chemotherapeutic agents are discontinued.III.Recovery following estrogen toxicosis is possible but variable.A.Recovery may occur within 3 months.B.Pancytopenia may be permanent in some cases.IV.Neutropenia associated with idiosyncratic drug reactions may resolve within 1 to 2 weeks after therapy is discontinued.V.Neutropenia induced by infectious diseases carries a fair (FeLV) to good (ehrlichiosis) prognosis.VI.Neutropenia associated with bone marrow necrosis and myelophthisic disease has a guarded prognosis, but recovery is possible with successful treatment of certain underlying causes, such as lymphoma.

Lymphocytosis {#cesec14}
-------------

See [Box 65-3](#cetextbox3){ref-type="boxed-text"} .Box 65-3Causes of Lymphocytosis\*\*Absolute lymphocyte counts \>2900/μL in dogs and \>7000/μL in cats.CausesSpecies AffectedPhysiological leukocytosis: epinephrine responseDog, catChronic antigenic stimulation Infectious agents  Bacteria: brucellosisDog  Mycoses: various speciesDog, cat  Rickettsia: *Ehrlichia canis,* Rocky Mountain spotted feverDog  Viruses: feline leukemia virusCat Vaccine-induced (acute response)Dog, catHypoadrenocorticismDogLymphoid neoplasia Acute or chronic lymphocytic leukemiaDog, cat LymphomaCat ThymomaCat© 2008 Iowa State University Press2008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.(Mahaffey EA: Quality control, test validity, and reference values. p. 331. In Latimer KS, Mahaffey, Prasse KW (eds): Duncan and Prasse\'s Veterinary Laboratory Medicine: Clinical Pathology. 4th Ed. Iowa State University Press, Ames, 2003)

Lymphopenia {#cesec15}
-----------

See [Box 65-4](#cetextbox4){ref-type="boxed-text"} .Box 65-4Causes of Lymphopenia\*\*Absolute lymphocyte counts \<400/μL in dogs and \<1500/μL in cats.CausesSpecies AffectedCorticosteroid-induced Increased endogenous corticosteroid levels  Acute severe stress: inflammation, infection, traumaDog, cat  HyperadrenocorticismDog Exogenous corticosteroid or ACTH administrationDog, catSepticemia or endotoxemiaDog, catAcute viral infections FeLV, panleukopenia, FIVCat Canine parvovirus, coronavirus, distemper, infectious hepatitisDogLoss of lymph fluid Chylothorax (see Chapter 19)Dog, cat ChyloperitoneumDog, cat LymphangiectasiaDog, cat Gastrointestinal disease  Protein-losing enteropathyDog  Ulcerative or granulomatous enteritisDog, cat Neoplasia  Gastrointestinal lymphomaDog, cat  Enteric tumorsDog, catLymph node effacement Granulomatous inflammation: numerous etiologiesDog, cat Multicentric lymphomaDog, catHereditary disorders Severe combined immunodeficiencyDog[†](#cetablefn1){ref-type="table-fn"} Treatment-induced Immunosuppressive drugsDog, cat Chemotherapeutic drugsDog, cat RadiationDog, cat[^4][^5]© 2008 Iowa State University Press2008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.(Mahaffey EA: Quality control, test validity, and reference values. p. 331. In Latimer KS, Mahaffey, Prasse KW (eds): Duncan and Prasse\'s Veterinary Laboratory Medicine: Clinical Pathology. 4th Ed. Iowa State University Press, Ames, 2003)

Monocytosis {#cesec16}
-----------

See [Box 65-5](#cetextbox5){ref-type="boxed-text"} .Box 65-5Causes of Monocytosis\*\*Absolute monocyte counts \>1400/μL in dogs and \>850/μL in cats.CausesSpecies AffectedAcute or chronic inflammation Protozoal, fungal, or parasitic diseases: numerous speciesDog, cat Bacterial diseases, particularly intracellular organisms such as *Mycobacterium* spp. or *Brucella* spp.Dog, cat Viral diseases: feline infectious peritonitis, FeLVCat Foreign-body reactionDog, cat Tissue necrosisDog, cat Immune-mediated diseases: hemolytic anemia, arthritisDog Pyogranulomatous inflammationDog, cat Neoplasia-associated inflammationDog, cat HemolysisDog, catCorticosteroid-induced leukocytosisCatRebound from neutropenia (may be first indicator of recovery) Recovery from neutropenia with inflammation, infection, systemic diseaseDog, cat Congenital cyclic hematopoiesis of gray-coated colliesDog Recovery from feline panleukopenia or canine parvovirusDog, catNeoplasia Monocytic leukemiaDog, cat Myelomonocytic leukemiaDog, cat Malignant histiocytosisDog[^6]© 2008 Iowa State University Press2008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.(Mahaffey EA: Quality control, test validity, and reference values. p. 331. In Latimer KS, Mahaffey, Prasse KW (eds): Duncan and Prasse\'s Veterinary Laboratory Medicine: Clinical Pathology. 4th Ed. Iowa State University Press, Ames, 2003)

Eosinophilia {#cesec17}
------------

See [Box 65-6](#cetextbox6){ref-type="boxed-text"} .Box 65-6Causes of Eosinophilia\*\*Absolute eosinophil counts \>1300/μL in dogs and \>750/μL in cats.CausesSpecies AffectedParasitic disease Heartworm diseaseDog, cat Nematodes: numerous speciesDog, cat Trematodes: various speciesDog, cat EctoparasitesDog, cat Protozoa: *Babesia canis, Hepatozoon americanum, H. canis, Pneumocystis carinii*Dog, cat Mycoses: *Cryptococcus neoformans, Aspergillus fumigatus, Pythium* spp., *Blastomyces dermatitidis*Dog, catImmediate or delayed hypersensitivity reactions Oral granulomaDog Gastrointestinal eosinophilic granulomaDog Ulcerative gastroenteritisDog, cat Pulmonary granulomaDog Pulmonary infiltrates with eosinophiliaDog AsthmaCat PanosteitisDog PyometraDog AtopyCat Feline eosinophilic granuloma complexCat Food hypersensitivityCat Eosinophilic keratitisCat Canine eosinophilic granulomaDogNeoplasia Eosinophilic leukemiaCat Myeloid leukemiaDog LymphomaCat Lymphomatoid granulomatosisDogParaneoplastic conditions Carcinomas: select typesDog, cat Sarcomas: select typesDog, cat Mast cell neoplasiaDog, catEndocrine conditions HypoadrenocorticismDog HyperthyroidismCat EstrusDogTetracycline administrationDogIdiopathic hypereosinophilic syndromeDog (rottweiler), cat© 2008 Iowa State University Press2008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.(Mahaffey EA: Quality control, test validity, and reference values. p. 331. In Latimer KS, Mahaffey, Prasse KW (eds): Duncan and Prasse\'s Veterinary Laboratory Medicine: Clinical Pathology. 4th Ed. Iowa State University Press, Ames, 2003)

Circulating Mast Cells {#cesec18}
----------------------

###  {#cesec19}

#### Definition {#cesec20}

Mast cells are rarely seen in peripheral blood smears, but can occur with certain conditions.

#### Causes {#cesec21}

I.Inflammatory conditions (dogs): allergic dermatitis, trauma, regenerative anemia, parvovirus infection, or non--mast cell neoplasia.II.Canine or feline metastatic mast cell neoplasiaIII.Mast cell leukemiaA.Myeloproliferative diseaseB.Atypical mast cells in circulation and in aspirate or biopsy samples from bone marrow, liver, and spleen

#### Diagnosis {#cesec22}

I.Occasional mast cells are seen in peripheral blood smears.II.Differentiation of mast cell leukemia from other conditions requires examination of cellular morphological characteristics, cytochemical staining, and histological examination of tissues.

#### Treatment {#cesec23}

I.When mast cells are seen in peripheral blood smears, the underlying disease should be identified and treated.II.See Chapter 70 for further discussion of treatment of mastocytosis.

Inflammatory Leukocytosis {#cesec24}
-------------------------

###  {#cesec25}

#### Definition {#cesec26}

I.Neutrophil supply released from the bone marrow exceeds the migration of neutrophils into sites of inflammation.II.The end result is an increase in circulating mature and immature neutrophils.

#### Causes and Pathophysiology {#cesec27}

I.Tissue demand for neutrophils exceeds the reserve of mature neutrophils in the bone marrow.A.Release of immature cells (left shift) in the following order: band cells, then metamyelocytes, then myelocytesB.Regenerative left shift1.It occurs with acute inflammation.2.It is characterized by increased numbers of WBCs (leukocytosis) that are predominantly mature neutrophils, with increased immature neutrophil precursors.C.Degenerative left shift1.The WBC count is normal to decreased with excessive numbers of immature relative to mature neu-trophils.2.It is often seen with septicemia or endotoxemia.3.Prognosis is poor, because tissue demand is greater than neutrophil production in the bone marrow.II.Neutrophilic responses vary with inflammation.A.Peracute inflammation1.Transient neutropenia develops within 1 to 3 hours.2.It is often in response to endotoxemia or severe infections, particularly those involving the peritoneum, lungs, or thorax.B.Acute inflammation1.Bone marrow responds within 4 to 6 hours to increased tissue demands, causing an accelerated release of neutrophils (mature and immature).2.The resulting inflammatory leukogram is characterized by leukocytosis, neutrophilia, and a regenerative left shift (generally \>450 immature neutrophilic precursors/μL in dogs or \>500 to 1000/μL in cats) ([@bib58]; [@bib13]).C.Chronic, prolonged (days to weeks) inflammation1.Characterized by leukocytosis with mature neutrophilia2.Results from expanded marrow production that exceeds tissue demand

Corticosteroid-Induced Leukocytosis (Stress Leukogram) {#cesec28}
------------------------------------------------------

###  {#cesec29}

#### Definition and Causes {#cesec30}

I.It is characterized by leukocytosis with mature neutro-philia, lymphopenia, and eosinopenia.II.Concurrent monocytosis is common in the dog and infrequent in the cat.III.It accompanies increased endogenous corticosteroid concentrations (severe stress or hyperadrenocorticism) or exogenous glucocorticoid or ACTH administration.

#### Diagnosis {#cesec31}

I.A CBC demonstrates the characteristic leukogram.A.WBC counts from 15,000 to 25,000/μL ([@bib58])B.Neutrophilia in the absence of a left shiftC.Lymphocyte count \<1000/μL ([@bib39])II.Stress leukogram can also occur concurrently with an inflammatory leukogram (see Inflammatory Leukocytosis).

Extreme Neutrophilic Leukocytosis (Leukemoid Response) {#cesec32}
------------------------------------------------------

###  {#cesec33}

#### Definition {#cesec34}

I.Pronounced leukocytosis from dramatic neutrophilia (up to 100,000/μL in dogs or 75,000/μL in cats), with a significant but orderly left shift ([@bib37]).II.Occasionally accompanied by eosinophilia or lymphocytosis

#### Causes and Pathophysiology {#cesec35}

I.It results from inflammation or nonhematopoietic neoplasia.II.It mimics granulocytic leukemia in cellular magnitude and composition.III.Several causes exist.A.Inflammation1.Localized infections: pyometra, peritonitis, pyothorax, pancreatitis2.Hepatazoonosis3.Hemolysis secondary to immune-mediated hemolytic anemiaa.Dogs: *Babesia canis*b.Cats: *Mycoplasma haemofelis, Mycoplasma haemominutum*B.Paraneoplastic conditions1.Production of hematopoietic-stimulating cytokines2.See Chapter 73C.Other causes1.Early estrogen toxicity2.Recombinant canine or human granulocyte-colony stimulating factor therapy3.Leukocyte adhesion protein deficiency in Irish setters

#### Diagnosis and Differential Diagnosis {#cesec36}

I.Differentiate from chronic myelogenous leukemia (CML).II.Both conditions have neutrophilic leukocytosis with a left shift, nonregenerative anemia, and increased myeloid: erythroid ratio, with orderly granulocytic maturation in the bone marrow.III.Suspect CML with a disorderly left shift, neutrophil dysplasia, thrombocytopenia, decreased marrow megakaryocytes, and granulopoietic precursors in extramedullary sites (liver, spleen, and lymph nodes).IV.Neutrophil toxicity, indicative of inflammatory conditions, drug toxicity, or systemic disease, is not typically a feature of CML.

Physiologic Leukocytosis {#cesec37}
------------------------

###  {#cesec38}

#### Definition {#cesec39}

I.Transient leukocytosis from epinephrine release with excitement, fear, or exercise that is characterized by mature neutrophilia and lymphocytosisII.Common in puppies and kittensIII.Uncommon in adult dogsIV.Rapid neutrophiliaA.Neutrophil count up to 39,000/μL in cats ([@bib39]) that generally diminishes within 20 minutesB.Neutrophilia often accompanied by lymphocytosis (absolute lymphocyte counts usually \<20, 000/μL) in young cats ([@bib13])

#### Causes and Pathophysiology {#cesec40}

I.NeutrophiliaA.It results from cellular shifts from the marginated to circulating pool.B.It is of greater magnitude in cats (larger marginated pool).II.Lymphocytosis: decreased migration into lymphoid tissue or increased mobilization from the thoracic ductIII.Monocyte and eosinophil numbers: unchanged or slightly increased

CONGENITAL DISORDERS OF WBCS {#cesec41}
============================

Morphologic and Functional Disorders {#cesec42}
------------------------------------

See [Table 65-3](#cetable3){ref-type="table"} .TABLE 65-3Morphological and Functional Disorders of Canine and Feline LeukocytesDISORDERINHERITANCECAUSESPECIESAPPEARANCE/CLINICAL SIGNSDIAGNOSISTREATMENTREFERENCESCyclic hematopoiesisAutosomal recessiveStem cell abnormalityGray-coated collie, collie- mix dogsContinuous abnormal hematological cyclesDecreased neutrophil number and function: recurrent bacterial infections, defective platelet aggregation, systemic amyloidosisSerial CBCs every 3-6 weeks: cyclic neutropenia and anemiaClinical signs: hair coat color dilutionBroad-spectrum antibiotics for sepsisLithium carbonate 21-26 μg/kg/day PO (potential side effects) rhG-CSF 5 μg/kg SCBID (watch for neutralizing antibodies)Bone marrow trans-plantation is curative[@bib8], [@bib40], [@bib49]Inherited vitamin B~12~ (cobalamin) malabsorptionAutosomal recessiveFailure to express intestinal intrinsic factor cobalamin complex receptor (cubilin)Inbred giant schnauzerNuclear chromatin maturation abnormalities, neutropenia, nonregenerative anemiaDecreased serum cobalamin concentrationClassic hematological abnormalitiesParenteral administration of megadose cobalamin (1 mg IM) monthlyNo improvement with oral cobalamin[@bib19]Birman cat neutrophil granulation anomalyAutosomal recessiveFine azurophilic granules similar to progranulocyte granulesBirman catProminent neutrophil granulationSerial CBCsDifferentiate from MPS VI, MPS VII, and toxic changeNone; neutrophils function normally[@bib29]Canine leukocyte adhesion deficiencyAutosomal recessiveDeficient expression of CD18 (subunit of B~2~ integrins)Irish setterRecurrent infections, marked neutrophilia, chronic anemiaBone marrow myeloid hyperplasiaFlow cytometry for neutrophil CD18 expressionAntibiotics alleviate signs but not infectionAffected animals usually die[@bib2]Pelger-Huët anomalyUncertain inheritanceAcquired secondary to sepsis, drugs,MPD, viral infectionsFailure of the mature nucleus to form true filamentsCats, dogsPeanut-shaped nuclei in granulocytes, monocytes, or megakaryocytesSerial CBCsNone; neutrophils function normallyChédiak-Higashi syndromeAutosomal recessiveFailure of granule fusionPersian catsYellow-green eyesSmoke-blue hair colorHypopigmentation of eyes, skin, hairCBC: neutropenia, abnormal granulesProlonged bleeding timesAbnormal platelet aggregationTemporary improvement with rhG-CSFBone marrow transplant[@bib46][^7]

Lysosomal Storage Diseases {#cesec43}
--------------------------

###  {#cesec44}

#### Definition and Causes {#cesec45}

I.Autosomal recessive genetic disorders characterized by multiple organ failure ([Table 65-4](#cetable4){ref-type="table"} )TABLE 65-4Lysosomal Storage Diseases of Dogs and CatsDISEASEENZYME DEFICIENCYBREEDS AFFECTEDWHITE BLOOD CELL ABNORMALITIESCLINICAL SIGNSMannosidosisα-[d]{.smallcaps}-MannosidaseEnglish springer spanielDSH, Persian catLymphocyte, neutrophil, eosinophil, monocyte cytoplasmic vacuolizationNeurological and skeletal abnormalitiesRetarded growthFacial dysmorphism (flattened features)Fucosidosisα-[l]{.smallcaps}-fucosidaseEnglish springer spanielLymphocyte vacuolizationBehavioral changesAtaxiaHearing and vision lossMPS Iα-[l]{.smallcaps}-iduronidasePlott houndDSH catsBasophilic to metachromatic (pink-purple) neutrophil cytoplasmic granulesLymphocyte granulation or vacuolizationSkeletal abnormalitiesFacial dysmorphismDwarfismCorneal opacitiesNeurologic abnormalitiesMPS VIArylsulfatase BSiamese and DSH catsMiniature pinscherSee MPS ISee MPS IMPS VIIβ-GlucuronidaseDogs, catsSee MPS ISee MPS IGM~1~ gangliosidosisβ-[d]{.smallcaps}-GalactosidaseSiamese, DSH catsBeagle, English springer spaniel, Portuguese water dog, mixed breed dogLymphocyte vacuolizationAtaxiaVisual deficitsGM~2~ gangliosidosisβ-[d]{.smallcaps}-HexosaminidaseKorat and DSH cats Japanese spanielNeutrophil granulationLymphocyte and/or eosinophil vacuolizationCorneal cloudingMuscle wastingCerebral and/or cerebellar dysfunction[^8]II.Intracellular accumulation of incompletely degraded substrates from deficiency of the lysosomal enzyme required for their metabolism

#### Diagnosis {#cesec46}

I.Examination of peripheral blood smears may reveal vacuolation or abnormal granules within leukocytes.II.Radiography helps characterize bony malformations in animals with clinically evident skeletal abnormalities.III.Identification of deficient lysosomal enzyme activity in plasma, leukocytes, or cultured skin fibroblasts can be attempted.IV.The structures of lysosomal enzymes are highly conserved; therefore, techniques developed for detection of enzymatic deficiencies in humans can be used in dogs and cats.V.Polymerase chain reaction (PCR)-based genomic screening can be used to identify some cases.A.Examples include dogs with fucosidosis, mucopolysaccharidosis (MPS) I, and MPS VII, and cats with MPS VI.B.Novel genetic mutations can occur with these diseases that may not be detected by the established testing procedures; therefore, a negative result does not eliminate a storage disease ([@bib60]).VI.Excessive urinary glycosaminoglycan excretion in animals with MPS can be detected by a urine spot test.

#### Treatment and Monitoring {#cesec47}

I.Storage diseases are generally untreatable and progressive.II.Bone marrow transplantation has resulted in clinical improvement in dogs with MPS I and cats with MPS VI.

NEOPLASIA {#cesec48}
=========

Myeloproliferative Disorders {#cesec49}
----------------------------

See Chapter 66.

Acute Lymphoblastic Leukemia {#cesec50}
----------------------------

###  {#cesec51}

#### Definition {#cesec52}

I.Acute lymphoblastic leukemia (ALL) is characterized by progressive lymphoblastic infiltration of lymphoid organs and bone marrow.II.Unlike lymphoma, the bone marrow is the primary tumor site.

#### Clinical Signs {#cesec53}

I.Affected animals present with nonspecific signs of anorexia, lethargy, weight loss, vomiting, diarrhea, lameness, altered mentation, and intermittent fever.II.Physical examination findings consist of pallor, hepatosplenomegaly, lymphadenopathy, and petechia.

#### Diagnosis {#cesec54}

I.Lymphocytosis with circulating lymphoblastsII.Anemia, thrombocytopenia, variable WBC counts, or pancytopeniaIII.Possible absence (aleukemia) or only small numbers (subleukemia) of circulating lymphoblastsIV.Possible bone marrow aspiration and/or biopsy findingsA.Homogeneous population of large immature lymphocytesB.Replacement of normal nucleated cell population with 40% to 50% lymphoblastsV.Possible clinical chemistry abnormalitiesA.Increased alanine and aspartate transferases (ALT, AST) and alkaline phosphatase (ALP) activities indicative of potential liver involvementB.Increased blood urea nitrogen concentration indicative of azotemia (prerenal or renal) or GI hemorrhageC.Hypercalcemia uncommon

#### Differential Diagnosis {#cesec55}

I.ALL is difficult to differentiate from multicentric lymphoma with bone marrow or blood involvement (stage V disease).II.Unlike advanced lymphoma, ALL often occurs without lymphadenopathy, is poorly responsive to chemotherapy, and has a more rapid and progressive disease course.III.Differentiation from acute myeloproliferative diseases (see Chapter 66) requires cytochemical and immunohistochemical staining of bone marrow preparations.IV.Lymphocytosis with mature, well-differentiated lymphocytes distinguishes chronic lymphocytic leukemia (CLL) from ALL (see below).V.Eliminate other causes of pancytopenia via bone marrow examination.

#### Treatment and Monitoring {#cesec56}

I.Treat ALL using established protocol treatments for canine or feline lymphoma ([@bib16]; [@bib12])A.Use of vincristine and L-asparaginase therapy together may result in neutropenia.B.Prognosis is poor, as treatment-induced remission is short and survival is generally less than a few months.II.Initiate broad-spectrum antibiotic therapy in animals with fever or neutropenia (\<1000/μL).III.For animals with anemia and/or thrombocytopenia, consider fresh whole blood, packed RBCs, platelet-rich plasma, or platelet concentrate transfusions (see Chapter 71).

Chronic Lymphocytic Leukemia {#cesec57}
----------------------------

###  {#cesec58}

#### Definition and Causes {#cesec59}

I.Chronic lymphocytic leukemia (CLL) is characterized by lymphocytic leukocytosis, with a predominance of small lymphocytes.II.There is no reported association between CLL and FeLV infection in cats.III.Most cases of CLL in dogs are of T-cell origin.IV.CLL is rare in cats.

#### Clinical Signs {#cesec60}

I.Possibly asymptomaticII.Nonspecific signs: lethargy, anorexia, weight loss, vomiting, diarrhea, polyuria/polydipsia, lamenessIII.Physical examination: hepatosplenomegaly, peripheral lymphadenopathy, pallor

#### Diagnosis {#cesec61}

I.CBC findingsA.Persistent marked lymphocytosisB.Lymphocyte counts: \>1,000,000/μL in dogs and up to 250,000/μL in cats ([@bib74])C.Concurrent hematological findings: nonregenerative, normocytic, normochromic anemia, thrombocytopenia, neutropenia, or pancytopenia from myelophthisisD.Findings in cats: not well characterizedII.Bone marrow aspirate and/or biopsy samples: \>30% small mature lymphocytesIII.Serum biochemistry resultsA.They can indicate multiple organ involvement.B.Serum and urine electrophoresis is indicated in dogs with hyperglobulinemia, as a monoclonal gammopathy occurs in up to 30% of dogs with hyperglobulinemia.IV.Immunophenotyping procedures ([@bib7])A.It uses PCR amplification of cellular DNA from peripheral blood.B.It identifies neoplastic populations of circulating small lymphocytes based on unique rearrangements of the T cell receptor g (T-cell lymphoma) or immunoglobulin (B-cell lymphoma) sequences.C.It helps to differentiate CLL from other nonneoplastic causes of persistent lymphocytosis, which can be difficult.

#### Differential Diagnosis {#cesec62}

I.Other causes of persistent lymphocytosisA.Transient leukocytosis (epinephrine response)B.Immune-mediated or other chronic, systemic diseasesC.Chronic ehrlichiosis, Rocky Mountain spotted fever and babesiosis infections (dogs), and toxoplasmosis (cats)II.Large granular lymphocyte (LGL) leukemiaA.LGL leukemia in cats is uncommon, may accompany lymphoma, and involves the alimentary tract or mesenteric lymph nodes.B.In dogs, LGL leukemia presents as either ALL or CLL.III.Acute lymphoblastic leukemiaIV.Multicentric lymphoma

#### Treatment and Monitoring {#cesec63}

I.Treatment for CLL is not often required, especially in the absence of bone marrow involvement and hematological abnormalities (anemia or other cytopenias), or evidence for multiorgan involvement (lymphadenopathy, splenomegaly, enzyme abnormalities).II.Chemotherapy is not recommended until the develop-ment of clinical signs, cytopenias, or marked lymphocytosis (generally defined as 60,000 to 100,000/μL).III.A combination protocol of oral chlorambucil and prednisone is effective dogs and cats ([@bib74]).A.Treatment in dogs involves the following:1.Chlorambucil: 0.2 mg/kg or 6 mg/m^2^ PO SID for 7 to 14 days, then 0.1 mg/kg or 3 mg/m^2^ PO SID, then long-term maintenance at 2.0 mg/m^2^ QOD2.Prednisone: 30 mg/m^2^ PO SID for 7 days, followed by 20 mg/m^2^ for 7 days and 10 mg/m^2^ QODB.Treatment in cats involves the following:1.Chlorambucil: 0.2 mg/kg or 2 mg/cat QOD2.Prednisone: 1 mg/kg SIDC.Dosages are modified based on clinical response.D.Monitor CBCs weekly for the first month and monthly thereafter.E.Prognosis is variable and depends on the extent of disease and response to therapy.

Sézary Syndrome in Dogs {#cesec64}
-----------------------

###  {#cesec65}

#### Definition and Cause {#cesec66}

I.Lymphoproliferative disease in dogs (uncommon) and cats (rare)II.Characterized by cutaneous lymphoma and a circulating population of large neoplastic T lymphocytes with in-tensely cleaved or indented nuclei and prominent nucleoli

#### Clinical Signs {#cesec67}

I.Ulcerative dermatitis, pruritus, anorexia, alopecia, and peripheral lymphadenopathyII.Hematologic abnormalitiesA.Lymphocytic leukocytosis with abnormal lymphocyte morphologyB.Possible monocytosis, neutrophilia, and nonregener-ative, normocytic, normochromic anemia

#### Diagnosis {#cesec68}

Dermal-epidermal infiltration by neoplastic lymphocytes in skin biopsy samples combined with the presence of circulating neoplastic lymphocytes.

#### Treatment and Monitoring {#cesec69}

I.Chemotherapeutic protocols for canine lymphoma can be tried.II.Prognosis is poor.

Absolute neutrophil counts \>12,000/μL in dogs and \>12,500/μL in cats.

Absolute neutrophil counts \<2900/μL in dogs and \<2500/μL in cats

Absolute lymphocyte counts \>2900/μL in dogs and \>7000/μL in cats.

Absolute lymphocyte counts \<400/μL in dogs and \<1500/μL in cats.

Absolute monocyte counts \>1400/μL in dogs and \>850/μL in cats.

Absolute eosinophil counts \>1300/μL in dogs and \>750/μL in cats.

[^1]: *EDTA,* Ethylenediamine tetraacetic acid.

[^2]: *ACTH,* Adrenocorticotropic hormone.

[^3]: *FeLV,* Feline leukemia virus; *FIV,* feline immunodeficiency virus.

[^4]: *ACTH,* Adrenocorticotropic hormone; *FeLV,* Feline leukemia virus; *FIV,* Feline immunodeficiency virus.

[^5]: Basset hound, Parson (Jack) Russell terrier, Cardigan Welsh corgi.

[^6]: *FeLV,* Feline leukemia virus.

[^7]: *CBC,* Complete blood count; *rhG-CSF,* recombinant human granulocyte-colony stimulating factor; *IM,* intramuscularly; *MPS,* mucopolysaccharidosis; *MPD,* myeloproliferative disease.

[^8]: *DSH,* Domestic short hair; *MPS,* mucopolysaccharidosis.
